Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 5811-5818

  Cavassani, Karen A ^a   Campanelli, Ana P ^a   Moreira, Ana P ^a   Vancim, Jaqueline O ^a   Vitali, Lucia H ^a   Mamede, Rui C ^a   Martinez, Roberto ^a   Silva, João S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CCL17 CHEMOKINE; CCL22 CHEMOKINE; CD4 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL MEMBRANE; CELL MIGRATION; CLINICAL ARTICLE; COCULTURE; CULTURE MEDIUM; CYTOKINE RELEASE; GRANULOMATOSIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MYCOSIS; PARACOCCIDIOIDES BRASILIENSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE;

EID: 33750291933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.5811     Document Type: Article

References (45)

1. Restrepo, A. 1985. The ecology of Paracoccidioides brasiliensis, a puzzle still unsolved. Sabouraudia 23: 323-334.
2. Franco, M., M. S. Montenegro, R. P. Mendes, A. S. Marques, N. L. Dillon, and N. S. Mota. 1987. Paracoccidioidomycosis: a recently proposed classification of its clinical form. Rev. Soc. Bras. Med. Trop. 20: 129-133.
3. Mota, N. G., M. T. Rezkallah-Iwasso, M. T. Peracoli, R. C. Audi, R. P. Mendes, J. Marcondes, S. A. Marques, N. L. Dillon, and M. F. Franco. 1985. Correlation between cell-mediated immunity and clinical forms of paracoccidioidomycosis. Trans. R. Soc. Trop. Med. Hyg. 79: 765-772.
4. Restrepo, A. 2000. Morphological aspects of Paracoccidioides brasiliensis in lymph nodes: implications for the prolonged latency of paracoccidioidomycosis? Med. Mycol. 38: 317-322.
5. Cano, L. E., S. S. Kashino, C. Arruda, D. Andre, C. F. Xidieh, L. M. Singer-Vermes, C. A. Vaz, E. Burger, and V. L. Calich. 1998. Protective role of γ interferon in experimental pulmonary paracoccidioidomycosis. Infect. Immun. 66: 800-806.
6. Souto, J. T., F. Figueiredo, A. Furlanetto, K. Pfeffer, M. A. Rossi, and J. S. Silva. 2000. Interferon-γ and tumor necrosis factor-α determine resistance to Paracoccidioides brasiliensis infection in mice. Am. J. Pathol. 156: 1811-1820.
7. Benard, G., M. A. Hong, G. M. Del Negro, L. Batista, M. A. Shikanai-Yasuda, and A. J. Duarte. 1996. Antigen-specific immunosuppression in paracoccidioidomycosis. Am. J. Trop. Med. Hyg. 54: 7-12.
8. Campanelli, A. P., G. A. Martins, J. T. Souto, M. S. Pereira, M. C. Livonesi, R. Martinez, and J. S. Silva. 2003. Fas-Fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis. J. Infect. Dis. 187: 1496-1505.
9. Benard, G., C. C. Romano, C. R. Cacere, M. Juvenale, M. J. Mendes-Giannini, and A. J. Duarte. 2001. Imbalance of IL-2, IFN-γ and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 13: 248-252.
10. Karhawi, A. S., A. L. Colombo, and R. Salomao. 2000. Production of IFN-γ is impaired in patients with paracoccidioidomycosis during active disease and is restored after clinical remission. Med. Mycol. 38: 225-229.
11. Mamoni, R. L., S. A. Nouer, S. J. Oliveira, C. C. Musatti, C. L. Rossi, Z. P. Camargo, and M. H. Blotta. 2002. Enhanced production of specific IgG4, IgE, IgA and TGF-β in sera from patients with the juvenile form of paracoccidioidomycosis. Med. Mycol. 40: 153-159.
12. Oliveira, S. J., R. L. Mamoni, C. C. Musatti, P. M. Papaiordanou, and M. H. Blotta. 2002. Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparison with infected and non-infected controls. Microbes Infect. 4: 139-212.
13. Mamoni, R. L., and M. H. Blotta. 2005. Kinetics of cytokines and chemokines gene expression distinguishes Paracoccidioides brasiliensis infection from disease. Cytokine 32: 20-29.
14. Cacere, C. R., C. C. Romano, M. J. Mendes Giannini, A. J. Duarte, and G. Benard. 2002. The role of apoptosis in the antigen-specific T cell hyporesponsiveness of paracoccidioidomycosis patients. Clin. Immunol. 105: 215-222.
15. + Tregs and immune control. J. Clin. Invest. 114: 1209-1217.
16. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
17. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
18. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360.
19. + T cells with regulatory properties from human blood. J. Exp. Med. 193: 1303-1310.
20. + regulatory T cell activity in both humans and mice. J. Immunol. 172: 834-842.
21. + regulatory T cells. Nat. Immunol. 4: 330-336.
22. Von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
23. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200: 201-210.
24. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
25. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
26. + T cell suppressor function. J. Immunol. 172: 6519-6523.
27. + Treg cells fit. Nat. Immunol. 6: 1071-1072.
28. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
29. Sugizaki, M. F., M. T. Peracoli, M. J. Mendes-Giannini, A. M. Soares, C. S. Kurokawa, R. P. Mendes, S. A. Marques, and D. V. Freire-Maia. 1999. Correlation between antigenemia of Paracoccidioides brasiliensis and inhibiting effects of plasma in patients with paracoccidioidomycosis. Med. Mycol. 37: 277-284.
30. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
31. Bava, A. J., A. S. Mistchenko, M. F. Palacios, M. E. Estevez, N. I. Tiraboschi, L. Sen, R. Negroni, and R. A. Diez. 1991. Lymphocyte subpopulations and cytokine production in paracoccidioidomycosis patients. Microbiol. Immunol. 35: 167-174.
32. high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
33. Miyara, M., Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, M. Kambouchner, D. Valeyre, C. Chapelon-Abric, P. Debre, et al. 2006. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203: 359-370.
34. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203: 777-788.
35. + Treg and control of Leishmania major infection. J. Immunol. 174: 5444-5455.
36. + regulatory T cells during acute graft-versus-host disease. Blood 106: 3300-3307.
37. Huehn, J., and A. Hamann. 2005. Homing to suppress: address codes for Treg migration. Trends Immunol. 26: 632-636.
38. Souto, J. T., J. C. Aliberti, A. P. Campanelli, M. C. Livonesi, C. M. Maffei, B. R. Ferreira, L. R. Travassos, R. Martinez, M. A. Rossi, and J. S. Silva. 2003. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-γ. Am. J. Pathol. 163: 583-590.
39. Reiss, Y., A. E. Proudfoot, C. A. Power, J. I. Campbell, and E. C. Butcher. 2001. CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194: 1541-1547.
40. Oswald-Richter, K., S. M. Grill, N. Shariat, M. Leelawong, M. S. Sundrud, D. W. Haas, and D. Unutmaz. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2: 955-966.
41. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
42. Bluestone, J. A. 2005. Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. 5: 343-349.
43. Romano, C. C., M. J. Mendes-Giannini, A. J. Duarte, and G. Benard. 2002. IL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidioidomycosis patients. Cytokine 18: 149-157.
44. + regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J. Immunol. 176: 5374-5387.
45. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169: 6298-6308.